ArticleDermatology and therapy2024

Baricitinib Improvement Across Regions in Atopic Dermatitis Patients with Baseline Body Surface Area up to 40% and Severe Itch.

José-Manuel Carrascosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.